2001
DOI: 10.1016/s1388-2457(01)00478-3
|View full text |Cite
|
Sign up to set email alerts
|

Remote F-wave changes after local botulinum toxin application

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
36
0

Year Published

2002
2002
2014
2014

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 41 publications
(36 citation statements)
references
References 31 publications
0
36
0
Order By: Relevance
“…In clinical practice, doses of BoNT/A vary widely depending on type of the disease and size of the muscles to be treated. Doses of BoNT/A ranging from 2 to 22 ng are typically reported for the treatment of torticollis spasmodicus and head/ neck dystonia (Garner et al, 1993;Wohlfarth et al, 2001). Comparison of these doses with those used by us suggests that retrograde transport may be a common occurrence after intramuscular delivery of BoNT/A.…”
Section: Comparison With Previous Studies and Clinical Implicationsmentioning
confidence: 79%
See 2 more Smart Citations
“…In clinical practice, doses of BoNT/A vary widely depending on type of the disease and size of the muscles to be treated. Doses of BoNT/A ranging from 2 to 22 ng are typically reported for the treatment of torticollis spasmodicus and head/ neck dystonia (Garner et al, 1993;Wohlfarth et al, 2001). Comparison of these doses with those used by us suggests that retrograde transport may be a common occurrence after intramuscular delivery of BoNT/A.…”
Section: Comparison With Previous Studies and Clinical Implicationsmentioning
confidence: 79%
“…Several papers have described changes at the level of the CNS in man and animals treated intramuscularly with BoNT/A (Garner et al, 1993;Giladi, 1997;Moreno-Lopez et al, 1997a,b;Kanovsky et al, 1998;Wohlfarth et al, 2001;Abbruzzese and Berardelli, 2006;Kim et al, 2006). For example, delivery of BoNT/A into the lateral rectus muscle of cats dramatically reduces the firing rates of abducens motoneurons projecting to the injected muscle (Moreno-Lopez et al, 1997a,b).…”
Section: Comparison With Previous Studies and Clinical Implicationsmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, although BoNT remains relatively localized at the site of injection by binding to the local nerve endings, side effects of BoNT therapy have been observed due to toxin diffusion [26]. Most often, the undesired effects are related to local toxin diffusion to the adjacent muscles, but in rare cases, adverse effects occur in distant muscles or result in central effects or generalized intoxication [1,63,66,67,87,146,185]. Systemic spreading and autonomic side effects, including mouth dryness, blurred vision, swallowing difficulties and constipation, are more often observed with BoNT/B than BoNT/A [44].…”
Section: Bont Disseminationmentioning
confidence: 99%
“…As a consequence alphamotoneuron activity is reduced even in non-treated muscles. 10 There are hints that surgical interventions intended to improve the ability to walk and stand are made possible and facilitated by treatment with botulinum toxin. Results are best when botulinum toxin is combined with physiotherapy and oral antispastic medication.…”
Section: Treatment Of Spasticitymentioning
confidence: 99%